169 related articles for article (PubMed ID: 31607933)
1. Corrigendum: Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis.
Li-Sha G; Li L; De-Pu Z; Zhe-Wei S; Xiaohong G; Guang-Yi C; Jia L; Jia-Feng L; Maoping C; Yue-Chun L
Front Pharmacol; 2019; 10():1126. PubMed ID: 31607933
[TBL] [Abstract][Full Text] [Related]
2. Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis.
Li-Sha G; Li L; De-Pu Z; Zhe-Wei S; Xiaohong G; Guang-Yi C; Jia L; Jia-Feng L; Maoping C; Yue-Chun L
Front Pharmacol; 2018; 9():182. PubMed ID: 29556195
[TBL] [Abstract][Full Text] [Related]
3. Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis.
Li YC; Luo Q; Ge LS; Chen YH; Zhou ND; Zhang T; Guan XQ; Lin JF
Biochem Biophys Res Commun; 2013 Feb; 431(3):450-5. PubMed ID: 23333383
[TBL] [Abstract][Full Text] [Related]
4. The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy.
Yue-Chun L; Guang-Yi C; Li-Sha G; Chao X; Xinqiao T; Cong L; Xiao-Ya D; Xiangjun Y
Front Pharmacol; 2016; 7():408. PubMed ID: 27847478
[TBL] [Abstract][Full Text] [Related]
5. Glutathione depletion and cardiomyocyte apoptosis in viral myocarditis.
Kytö V; Lapatto R; Lakkisto P; Saraste A; Voipio-Pulkki LM; Vuorinen T; Pulkki K
Eur J Clin Invest; 2004 Mar; 34(3):167-75. PubMed ID: 15025674
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis.
Liu T; Yang F; Liu J; Zhang M; Sun J; Xiao Y; Xiao Z; Niu H; Ma R; Wang Y; Liu X; Dong Y
Exp Anim; 2019 Nov; 68(4):549-558. PubMed ID: 31243190
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte apoptosis after antiviral WIN 54954 treatment in murine coxsackievirus B3 myocarditis.
Kytö V; Saraste A; Fohlman J; Ilbäck NG; Harvala H; Vuorinen T; Hyypiä T
Scand Cardiovasc J; 2002 May; 36(3):187-92. PubMed ID: 12079640
[TBL] [Abstract][Full Text] [Related]
8. Effects of levosimendan in experimental acute coxsackievirus myocarditis.
Latva-Hirvelä J; Kytö V; Saraste A; Vuorinen T; Levijoki J; Saukko P
Eur J Clin Invest; 2009 Oct; 39(10):876-82. PubMed ID: 19772522
[TBL] [Abstract][Full Text] [Related]
9. Development of troponin autoantibodies in experimental coxsackievirus B3 myocarditis.
Latva-Hirvelä J; Kytö V; Saraste A; Eriksson S; Vuorinen T; Pettersson K; Saukko P
Eur J Clin Invest; 2009 Jun; 39(6):457-62. PubMed ID: 19397694
[TBL] [Abstract][Full Text] [Related]
10. Effect of astragaloside on cardiomyocyte apoptosis in murine coxsackievirus B3 myocarditis.
Zhang ZC; Li SJ; Yang YZ; Chen RZ; Ge JB; Chen HZ
J Asian Nat Prod Res; 2007 Mar; 9(2):145-51. PubMed ID: 17454311
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis.
Saraste A; Arola A; Vuorinen T; Kytö V; Kallajoki M; Pulkki K; Voipio-Pulkki LM; Hyypiä T
Cardiovasc Pathol; 2003; 12(5):255-62. PubMed ID: 14507574
[TBL] [Abstract][Full Text] [Related]
12. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy.
Chapman NM; Kim KS
Curr Top Microbiol Immunol; 2008; 323():275-92. PubMed ID: 18357775
[TBL] [Abstract][Full Text] [Related]
13. Melatonin Ameliorates Coxsackievirus B3-Induced Myocarditis by Regulating Apoptosis and Autophagy.
Sang Y; Gu X; Pan L; Zhang C; Rong X; Wu T; Xia T; Li Y; Ge L; Zhang Y; Chu M
Front Pharmacol; 2018; 9():1384. PubMed ID: 30564119
[TBL] [Abstract][Full Text] [Related]
14. Role of Heart Rate Reduction in the Management of Myocarditis.
Guang-Yi C; Li-Sha G; Yue-Chun L
Curr Pharm Des; 2018; 24(3):365-378. PubMed ID: 29332571
[TBL] [Abstract][Full Text] [Related]
15. The viral genome in experimental murine Coxsackievirus B3 myocarditis: a Northern blotting analysis.
Okada I; Matsumori A; Kawai C; Yodoi J; Tracy S
J Mol Cell Cardiol; 1990 Sep; 22(9):999-1008. PubMed ID: 2177795
[TBL] [Abstract][Full Text] [Related]
16. Ivabradine improved left ventricular function and pressure overload-induced cardiomyocyte apoptosis in a transverse aortic constriction mouse model.
Yu Y; Hu Z; Li B; Wang Z; Chen S
Mol Cell Biochem; 2019 Jan; 450(1-2):25-34. PubMed ID: 29790114
[TBL] [Abstract][Full Text] [Related]
17. Low-dose N omega-nitro-L-arginine methyl ester treatment improves survival rate and decreases myocardial injury in a murine model of viral myocarditis induced by coxsackievirus B3.
Mikami S; Kawashima S; Kanazawa K; Hirata K; Hotta H; Hayashi Y; Itoh H; Yokoyama M
Circ Res; 1997 Oct; 81(4):504-11. PubMed ID: 9314831
[TBL] [Abstract][Full Text] [Related]
18. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis.
Rezkalla S; Kloner RA; Khatib G; Khatib R
Circulation; 1990 Mar; 81(3):1039-46. PubMed ID: 2155071
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction.
Zhang L; Chen J; Yan L; He Q; Xie H; Chen M
Front Pharmacol; 2022; 13():857367. PubMed ID: 35370721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
